John P. Redrobe
Valby, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Mice heterozygous for an inactivated allele of the schizophrenia associated Brd1 gene display selective cognitive deficits with translational relevance to schizophrenia.
Journal: Neurobiology of learning and memory
Published: December 07, 2016
Characterisation of Lu AF33241: A novel, brain-penetrant, dual inhibitor of phosphodiesterase (PDE) 2A and PDE10A.
Journal: European journal of pharmacology
Published: January 09, 2015
Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia.
Journal: Physiology & behavior
Published: October 01, 2014
In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia.
Journal: Psychopharmacology
Published: October 16, 2013
Discovery and optimization of Lu AF58801, a novel, selective and brain penetrant positive allosteric modulator of alpha-7 nicotinic acetylcholine receptors: attenuation of subchronic phencyclidine (PCP)-induced cognitive deficits in rats following oral administration.
Journal: Bioorganic & medicinal chemistry letters
Published: September 06, 2013
A combined α7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances.
Journal: Neuropharmacology
Published: February 18, 2013
RO4938581, a GABAAα5 modulator, displays strong CYP1A2 autoinduction properties in rats.
Journal: Biochemical pharmacology
Published: December 19, 2012
CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate.
Journal: Frontiers in pharmacology
Published: December 20, 2011
Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats.
Journal: Psychopharmacology
Published: July 14, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026